Share this article
KindlyMD faces Nasdaq delisting risk after failing to meet minimum share price levels
The health-care and bitcoin treasury firm has six months to lift its share price above $1 for 10 consecutive days.
Dec 16, 2025, 10:09 a.m.
Make us preferred on Google
What to know:
- The Nasdaq exchange told KindlyMD (NAKA) that it faces being delisted after its share price dropped below $1 for 30 consecutive business days.
- The health-care company that is building a bitcoin treasury has until June 8 to regain compliance, which requires the stock to close at or above $1 for at least 10 consecutive business days.
- The shares first fell below $1 in late October, and closed Monday at $0.38.
Kindly MD (NAKA), a health-care and bitcoin treasury company company, faces being delisted from the Nasdaq exchange after its share price failed to meet minimum listing requirements.
The stock has closed below $1 for 30 consecutive trading days, and the company has until June 8 to lift it above that level for 10 straight days to avoid the delisting, it said in an SEC filing on Dec. 12.
STORY CONTINUES BELOW
Don't miss another story.Subscribe to the Crypto Daybook Americas Newsletter today. See all newsletters
The company was bought in a reverse takeover by Nakomoto in August, which kept the KindlyMD name and changed the stock ticker. It owns 5,398 BTC ($466 million) and is the 19th largest corporate holder of bitcoin, according to the BitcoinTreasuries.net.
The shares, which surged to a record in May when the deal was announced, have since slumped 99% and closed Monday at 38 cents, a 0.817 multiple of the net asset value (mNAV).
If the shares don't meet the listing requirement by June, there are still avenues open. Nasdaq may grant an extension, the company could potentially address the issue through a reverse stock split or it may apply to transfer to the Nasdaq Capital Market.
Read more: KindlyMD Turns to Kraken as Fourth Provider for Bitcoin-Backed $210M Loan at 8%
AI Disclaimer: Parts of this article were generated with the assistance from AI tools and reviewed by our editorial team to ensure accuracy and adherence to our standards. For more information, see CoinDesk's full AI Policy.
More For You
More For You
Crypto custodian BitGo a potential acquisition target for Wall Street firms, analysts say
Compass Point and Canaccord call BitGo a potential acquisition target and defend the stock despite its weak debut, citing growth in institutional crypto infrastructure.
What to know:
- Wall Street analysts say BitGo’s expansion into full-service institutional crypto finance could drive long-term growth and make it an attractive acquisition target for traditional financial firms.
- Analysts argue that investors are overlooking BitGo’s potential to cross-sell prime brokerage-style services, which could significantly boost revenue if it can narrow the gap with rivals like Galaxy and Coinbase.
- Despite BitGo’s stock falling more than 40% since its January IPO, some analysts view the selloff as an overreaction and maintain buy ratings, citing the company’s solid competitive moat and strategic value to big banks entering crypto.
